AXIN1 and hepatocellular carcinoma: Various human cancers including HCC manifest abnormal β-catenin/TCF/LEF transactivation due to mutations in Wnt/β-catenin signaling pathway such as β-catenin, APC, axin, etc. [2]–[7].